Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Alnylam Pharmaceuticals, Inc.

ALNY•NASDAQ
Healthcare
Biotechnology
$313.41
$-3.82(-1.20%)
U.S. Market opens in 14h 36m

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

ALNY Technical Analysis Summary

Alnylam Pharmaceuticals, Inc. stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.

Overall Sentiment:Sell
Momentum:Bearish to Weak (RSI: 38.84)
Trend Strength:Moderate (ADX: 26.38)
Volatility:Medium (ATR: 11.03)
Support/Resistance:$310.23 – $341.08 (Bollinger Bands)

This mix signals that Alnylam Pharmaceuticals, Inc. is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 38.84

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 26.13

Bearish
Momentum remains weak below midpoint.

Williams %R: -76.70

Bearish
Sellers maintain momentum below neutral.

Rate of Change (ROC): -5.68

Strongly Bearish
Sharp downside momentum.

Takeaway:Alnylam Pharmaceuticals, Inc. shows weakening momentum, with sellers gaining the edge.

Trend & Volatility

MACD: -7.21

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 26.38

Moderate
Moderate trend, direction gaining strength.

ATR (14): 11.03

Rising
Rising volatility, market activity increasing.

CCI (14): -120.27

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Alnylam Pharmaceuticals, Inc. shows oversold trend conditions, with potential for rebound if buyers step in.

Support & Resistance indicators
Bollinger Bands
Upper Band
$341.08
Middle Band (SMA 20)
$325.66
Lower Band
$310.23
Current Position
Within Bands

Takeaway:Alnylam Pharmaceuticals, Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$349.29
Middle Line (EMA 20)
$327.23
Lower Channel
$305.16
Squeeze Status
Squeeze On

Takeaway:Alnylam Pharmaceuticals, Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume1.75M
Money Flow Index33.31Bearish, selling pressure outweighs inflows.
Relative Vigor Index43.84Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:ALNY shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of Alnylam Pharmaceuticals, Inc., here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Alnylam Pharmaceuticals, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.

Technical Analysis FAQ